Psychotropic Polypharmacy Among Youths Enrolled in Medicaid
Authors:
Open Access
- 5 February 2024
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (2) , e2356404
Abstract
Concomitant use of medications for attention-deficit/hyperactivity disorder (ADHD), antipsychotics, mood-stabilizing anticonvulsants, and antidepressants is referred to as psychotropic polypharmacy.1 Over the past 2 decades, psychotropic polypharmacy in youths increased, raising safety concerns.2-4 Our goal was to examine trends from 2015 to 2020 in psychotropic polypharmacy among youths aged 17 years or younger who were enrolled in Medicaid to identify temporal changes and characteristics associated with psychotropic polypharmacy.Keywords
This publication has 5 references indexed in Scilit:
- Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid EnrolleesJournal of Child and Adolescent Psychopharmacology, 2023
- Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and CommentaryFrontiers in Psychiatry, 2021
- Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999–2010Psychiatric Services, 2018
- Polypharmacy and the Pursuit of Appropriate Prescribing for Children and AdolescentsChild and Adolescent Psychopharmacology News, 2017
- Trends in Psychotropic Polypharmacy Among Youths Enrolled in Ohio Medicaid, 2002–2008Psychiatric Services, 2014